Business
Akanda Announces Arrival of First Shipment and Sales of Medical Cannabis to Germany
Akanda announces first export shipment to Germany of high THC indoor cultivated premium cannabis from its Portugal-based operation Akanda is enabling sales
About this update from Akanda Corp.
[{"type":"text","content":"\n\nAkanda announces first export shipment to Germany of high THC indoor cultivated premium cannabis from its Portugal-based operation\n\n\nAkanda is enabling sales of medical cannabis for patients across Germany\n\n\nAkanda stands ready to serve legal adult-use markets in Europe once established\n\n\n LONDON--(BUSINESS WIRE)--\nInternational medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) expects to take a leading position in the fast-growing German medical cannabis market, as it sees its first export shipment arrive from its Portugal-based operation and announces the first sale has been achieved, solidifying the company as operationally profitable in the market. Akanda recently entered into an agreement to deliver at least 1,000 kilograms of high-grade medical cannabis flower to Germany through the Cansativa platform. The deal ranks as one of the largest supply agreements in the European medical cannabis industry. Cansativa is also the only company in Germany permitted to distribute domestically grown cannabis.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221108005705/en/Akanda announces first export shipment to Germany of high THC indoor cultivated premium cannabis from its Portugal-based operation (Photo: Business Wire)\n“This is an impressive milestone for Akanda’s push into the German medical cannabis market. The successful arrival of our first shipment of flower to supply patients through the Cansativa platform is an indication of the market’s demand for premium high THC medical cannabis,” commented Akanda’s CEO Tej Virk. “Our Portugal-based EU GMP-certified medical cannabis cultivation operation hosts a one-of-a-kind 20,000 square foot indoor premium cultivation site in Sintra and a 7 million square foot (180+ acres) outdoor site in Aljustrel. Akanda is dedicated to fulfilling supply agreements and delivering high THC, non-irradiated, premium quality standard medical cannabis flower to the market. Our premium medical cannabis flower has tested as high as 28% THC and the Sintra indoor facility has produced approximately 1,200kg to date.”\n\nGermany’s health minister recently released initial guidelines for adult-use legalization in the country. “We applaud the German government’s push forward in maintaining their lea...